Ascend Capital’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
Sell
-34,306
Closed -$35K 195
2016
Q3
$35K Sell
34,306
-16,408
-32% -$16.7K ﹤0.01% 118
2016
Q2
$74K Buy
+50,714
New +$74K ﹤0.01% 138